|
FAM45B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31560000005138E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1249000000001E-05 |
| Normal-vs-Stage2 |
3.039100E-04 |
| Normal-vs-Stage3 |
1.72102000000063E-05 |
| Normal-vs-Stage4 |
6.20679999999707E-05 |
| Stage1-vs-Stage2 |
7.164200E-01 |
| Stage1-vs-Stage3 |
5.366200E-01 |
| Stage1-vs-Stage4 |
5.340400E-01 |
| Stage2-vs-Stage3 |
9.323000E-01 |
| Stage2-vs-Stage4 |
8.415600E-01 |
| Stage3-vs-Stage4 |
8.861600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26330000002917E-06 |
| Normal-vs-AfricanAmerican |
3.236400E-02 |
| Normal-vs-Asian |
1.8320699999963E-05 |
| Caucasian-vs-AfricanAmerican |
4.041800E-01 |
| Caucasian-vs-Asian |
2.306000E-01 |
| AfricanAmerican-vs-Asian |
1.167450E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.07650000000537E-06 |
| Normal-vs-Female |
3.816799999945E-06 |
| Male-vs-Female |
3.884400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.162690E-04 |
| Normal-vs-Age(41-60Yrs) |
2.07910000005196E-06 |
| Normal-vs-Age(61-80Yrs) |
8.11540000000832E-05 |
| Normal-vs-Age(81-100Yrs) |
2.097400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.728000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.375800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.484600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.807600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.809400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.516000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.179200E-01 |
| Classical-VS-Follicular |
2.837400E-01 |
| Classical-VS-Other |
3.136600E-01 |
| Classical-VS-Normal |
2.16449999999035E-05 |
| Tall-VS-Follicular |
3.893400E-01 |
| Tall-VS-Other |
3.000600E-01 |
| Tall-VS-Normal |
4.636100E-03 |
| Follicular-VS-Other |
6.310600E-01 |
| Follicular-VS-Normal |
1.014790E-04 |
| Other-VS-Normal |
1.427560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55589999999428E-05 |
| Normal-vs-N1 |
5.04920000032882E-07 |
| N0-vs-N1 |
5.204200E-02 |
|
|
